Global Syringes Market Size & Share - Global Forecast to 2026

The worldwide syringe market is estimated to reach $15.99 billion by 2026, up from $10.56 billion in 2016, with a CAGR of 8.7% over the forecast period. The market for syringes is growing due to a high prevalence of chronic diseases around the world, a growing elderly population, increased acceptance of safety syringes, technical improvements, and increased demand for vaccines. The high cost of safety syringes and the rising prevalence of needle stick injuries, however, are the market's primary hurdles.

For companies involved in the development and manufacturing of syringes, emerging Asia-Pacific regions provide significant growth opportunities. The key factors driving the market include increasing technological breakthroughs, global companies' increased focus, fast urbanisation, favourable regulatory policies for the approval of new injectables, and rapid expansion in the elderly population.

The sizes and growth rates of the syringes market and its subsegments were calculated using a combination of bottom-up and top-down methodologies. Secondary sources were used to determine percentage shares, splits, and breakdowns, which were then validated using primary sources. To obtain the final quantitative and qualitative data, all conceivable parameters that affect the markets covered in this research study have been accounted for, viewed in great depth, validated by primary research, and assessed. To calculate the percentage shares of each product around the world, primary interviews with important opinion leaders were conducted. For all subsegments, the research gives qualitative insights into growth rates and market drivers. It plots market sizes and growth rates for each subsegment and finds fast-growing segments.

The worldwide syringes market is divided into two basic groups based on usability: sterilizable/reusable syringes and disposable syringes. In 2016, the disposable market is expected to have the largest proportion of the global market. The increased use of injectables as a form of drug delivery, the ageing population, the high infection risks associated with reusing syringes, and the increasing propensity toward self-administration can all be linked to this segment's considerable share.